CT Scan Should Follow Benign Fine Needle Biopsy of Lung Nodules
FNAs may produce too many false negatives. Follow up imaging suggested.
Fine needle biopsies (FNA) for suspicious lung nodules may produce false negatives and should be followed by an additional CT scan, according to research published in the latest issue of Journal of Thoracic Oncology.
Researchers from the Weill Cornell Medical College and Mount Sinai Hospital in New York City investigated the results from 170 patients who underwent an FNA biopsy that was found to be benign and found with CT follow up that 18 of these results were false negatives, 152 were true negatives.
There were several factors that associated with false negative results, said the researchers. These include false negative nodules being significantly larger than true negative nodules (mean, 27 mm versus 17 mm, p = 0.04), fewer imaging adjustments per needle pass (4.5 versus 6.4, p = 0.01), a higher proportion in whom the needle tip was not documented within the lesion (24% versus 5%, p =0.04), and a higher pneumothorax rate at any point during the procedure (50% versus 22%, p =0.04). There was also the lack of positive cultures.
When these variables were considered jointly, pneumothorax, solitary nodule, and the radiologist who performed the procedure were significant predictors of false negative results.
“A benign FNA biopsy result should have the procedure reviewed to ensure that results are reliable,” the researchers concluded.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
